東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Metabolism- Disorders" ]

切換: 標籤 | MARC模式 | ISBD

Non-coding RNAs at the cross-road of...

Holvoet, Paul.

FindBook

Google Book

Amazon

博客來

Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer/ by Paul Holvoet.
作者:	Holvoet, Paul.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	xxx, 265 p. :ill. (some col.), digital ;24 cm.
內容註:	Biogenesis and Modes of Action Of miRs And Circular And Long Non-coding RNAs -- Obesity, Insulin Resistance in Adipose Tissue And Thermogenesis -- Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease -- Atherosclerosis -- Cardiomyopathy and Heart Failure -- Cancer -- Communication between Tumor-Adjacent Tissues and Tumors with Emphasis on Role of Inflammatory Cells -- General Conclusions and Future Perspectives.
Contained By:	Springer Nature eBook
標題:	Non-coding RNA. -
電子資源:	https://doi.org/10.1007/978-3-030-68844-8
ISBN:	9783030688448

Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer
Holvoet, Paul.

Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer[electronic resource] /by Paul Holvoet. - Cham :Springer International Publishing :2021. - xxx, 265 p. :ill. (some col.), digital ;24 cm.

Biogenesis and Modes of Action Of miRs And Circular And Long Non-coding RNAs -- Obesity, Insulin Resistance in Adipose Tissue And Thermogenesis -- Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease -- Atherosclerosis -- Cardiomyopathy and Heart Failure -- Cancer -- Communication between Tumor-Adjacent Tissues and Tumors with Emphasis on Role of Inflammatory Cells -- General Conclusions and Future Perspectives.

This book gives insight into the functional role of non-coding RNAs in central pathways contributing to the development of obesity, type 2 diabetes, non-alcoholic fatty liver disease, atherosclerosis, myocardial infarction, cardiomyopathy, and heart failure. It also sheds light on the relationship of this cluster with cancer. Tumor cells, in contrast to cells in cardiometabolic tissues, can regulate this cluster of non-coding RNAs to escape from oxidative stress and anti-tumor immunity and maintain insulin sensitivity, facilitating cancer progression. The book presents a cluster of non-coding RNAs that may be prospectively analyzed in extensive cohort studies to determine their value in risk-predicting machine learning algorithms. In addition, it emphasizes the role of microvesicles in communication between tumor-adjacent tissue, inflammatory cells, and tumor cells, with a special focus on the role of miR-155. The book intends to promote interdisciplinary research. Due to the comprehensive background information provided in each chapter, it is suitable for researchers in academia and industry and for graduate students in biology, bioengineering, and medicine.

ISBN: 9783030688448

Standard No.: 10.1007/978-3-030-68844-8doiSubjects--Topical Terms:

923507
Non-coding RNA.

LC Class. No.: QP623

Dewey Class. No.: 572.88

Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer
LDR:02594nmm a2200325 a 4500 001 2238740
003 DE-He213
005 20210621143050.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030688448 $q (electronic bk.)
020 $a 9783030688431 $q (paper)
024 7 $a 10.1007/978-3-030-68844-8 $2 doi
035 $a 978-3-030-68844-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP623
072 7 $a PSAK $2 bicssc
072 7 $a SCI029000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 572.88 $2 223
090 $a QP623 $b .H758 2021
100 1 $a Holvoet, Paul. $3 3492107
245 1 0 $a Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer $h [electronic resource] / $c by Paul Holvoet.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xxx, 265 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Biogenesis and Modes of Action Of miRs And Circular And Long Non-coding RNAs -- Obesity, Insulin Resistance in Adipose Tissue And Thermogenesis -- Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease -- Atherosclerosis -- Cardiomyopathy and Heart Failure -- Cancer -- Communication between Tumor-Adjacent Tissues and Tumors with Emphasis on Role of Inflammatory Cells -- General Conclusions and Future Perspectives.
520 $a This book gives insight into the functional role of non-coding RNAs in central pathways contributing to the development of obesity, type 2 diabetes, non-alcoholic fatty liver disease, atherosclerosis, myocardial infarction, cardiomyopathy, and heart failure. It also sheds light on the relationship of this cluster with cancer. Tumor cells, in contrast to cells in cardiometabolic tissues, can regulate this cluster of non-coding RNAs to escape from oxidative stress and anti-tumor immunity and maintain insulin sensitivity, facilitating cancer progression. The book presents a cluster of non-coding RNAs that may be prospectively analyzed in extensive cohort studies to determine their value in risk-predicting machine learning algorithms. In addition, it emphasizes the role of microvesicles in communication between tumor-adjacent tissue, inflammatory cells, and tumor cells, with a special focus on the role of miR-155. The book intends to promote interdisciplinary research. Due to the comprehensive background information provided in each chapter, it is suitable for researchers in academia and industry and for graduate students in biology, bioengineering, and medicine.
650 0 $a Non-coding RNA. $3 923507
650 0 $a Metabolism $x Disorders $x Molecular aspects. $3 2145885
650 0 $a Cardiovascular system $x Diseases $x Molecular aspects. $3 907466
650 0 $a Cancer $x Genetic aspects. $3 669248
650 0 $a Genetic regulation. $3 600658
650 1 4 $a Genetics and Genomics. $3 3385208
650 2 4 $a Physiology. $3 518431
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Biomedicine, general. $3 3446035
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-68844-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)